Epic Pipeline Fail: Pfizer to drop intravenous Alzheimer's drug

[Anonymous]

Pfizer and J&J end testing of intravenous bapineuzumab Alzheimer's treatment

Bloodbath cost cuts upcoming.

http://finance.yahoo.com/news/j-j-pfizer-drop-intravenous-232735506.html

http://www.nytimes.com/2012/08/07/business/alzheimers-drug-trials-halted.html

http://www.bloomberg.com/news/2012-08-06/pfizer-j-j-drop-alzheimer-s-drug-studies-after-failure.html

 

[Anonymous]

Pfizer and J&J end testing of intravenous bapineuzumab Alzheimer's treatment

Bloodbath cost cuts upcoming.

http://finance.yahoo.com/news/j-j-pfizer-drop-intravenous-232735506.html

http://www.nytimes.com/2012/08/07/business/alzheimers-drug-trials-halted.html

http://www.bloomberg.com/news/2012-08-06/pfizer-j-j-drop-alzheimer-s-drug-studies-after-failure.html

What a joke our R&D has become. Two studies both ending in utter failure. With the gene/without the gene, doesn't matter, no improvement. Sad.....

I wonder if someone had a TBO stating: "1. successfully get bapineuzumab thru phase 3 trials. 2. Launch drug soon after, 3. $400mm sales first 3 months after launch"

Hate to see that mid year!!

 

[Anonymous]

Win a few and lose a lot...that's R+D

 

[Anonymous]

Upper management and R&D executing flawlessly

 

[Anonymous]

More Ph.Ds to hit the street. R&D exacted their revenge on Ian Read's axe to their budget. Read one the budget battle, but lost the R&D war. Wyeth would have had this product commercialized by now.

 

[Anonymous]

$5 billion in research, flushed.